US Patent 7566785 Amidine substituted aryl aniline compounds
Patent 7566785 was granted and assigned to Theravance on July, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
John R. Jacobsen0
Martin S. Linsell0
Ningning Xu0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+336 characters)
Article
Patent abstract
The invention provides novel β2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07566785 Amidine substituted aryl aniline compounds US Patent 7566785 Amidine substituted aryl aniline compounds
Infobox
Patent Number
075667850
Patent Number
75667850
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075667850
Date of Patent
July 28, 2009
0Patent Application Number
112224130
Date Filed
September 8, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07566785 Amidine substituted aryl aniline compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07566785
Date of patent
July 28, 2009
Patent application number
11222413
Date Filed
September 8, 2005
Patent primary examiner
Find more entities like US Patent 7566785 Amidine substituted aryl aniline compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
